300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Taiwan
Liberia
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Oman
Tajikistan
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
United Kingdom
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
L1 Capital, VC Fund

L1 Capital

VC Fund

Melbourne, Australia

L1 Capital is a boutique fund manager based in Melbourne committed to offering best in class investment products. The firm invests for wholesale clients, primarily superannuation funds, large institutions and high net worth individuals and has been one of Australia’s top performing Australian equity fund managers since its inception in 2007.

Total investments:
10
Last investment:
Lead investor:
70%

Last updated:

Industries L1 Capital invests in

MineralBiotechnologyMiningHealth CarePrecious Metals

Stages L1 Capital invests in

Post-IPO EquityPost-IPO Debt

Countries L1 Capital invests in

AustraliaUnited StatesCanadaFrance

Contacts

NameEmailPhoneSocials
Andrew Lin Andrew Lin
Mark Landau Mark Landau
Raphael Lamm Raphael Lamm

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Mineral 4 (40%)
  • Biotechnology 4 (40%)
  • Mining 3 (30%)
  • Health Care 3 (30%)
  • Precious Metals 3 (30%)
See all 19 industries →

Stage

  • Post-IPO Equity 7 (70%)
  • Post-IPO Debt 3 (30%)

Country

  • Australia 6 (60%)
  • United States 2 (20%)
  • Canada 1 (10%)
  • France 1 (10%)

Team

NameTitleInvestmentsLinksEmail
Andrew Lin
Andrew Lin Senior Investment Analyst
Senior Investment Analyst Total investments: 0 Find email
Mark Landau
Mark Landau Co-founder, CIO & JMD
Co-founder, CIO & JMD Total investments: 0 Find email
Raphael Lamm
Raphael Lamm Co-founder, CIO & JMD
Co-founder, CIO & JMD Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Advicenne Advicenne
Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Parisand Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France. $1.7M / Post-IPO Debt / Jun 22, 2026
Resolution Minerals Resolution Minerals
Resolution Minerals is engaged in the acquisition, exploration, and development of precious and battery metals, such as gold, copper, cobalt, and uranium. They are involved in the exploration of the Wollongong copper cobalt project. $14.3M / Post-IPO Equity / Apr 22, 2026
Elementos Elementos
Elementos is a tin exploration and development company with assets in mature mining. They commit to the exploration, development, production, and transport of tin, regardless of where they operate. $20.9M / Post-IPO Equity / Feb 16, 2026
Rox Resources Rox Resources
Rox Resources is an Australian multi-commodity exploration company with three key projects: the Mt Fisher gold project in Western Australia, and the Reward zinc-lead project and Marqua phosphate project, both located in the Northern Territory. $132.8M / Post-IPO Equity / Dec 09, 2025
Kuya Silver Kuya Silver
Kuya Silver focuses on acquiring, exploring, and advancing precious metals assets. The company also provides acquisition, exploration, and development of grade silver ore with lead and zinc by-products. $1M / Post-IPO Debt / Oct 10, 2024
Hancock Jaffe Laboratories Hancock Jaffe Laboratories
Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of currentprocedures in concert with a commitment to efficient health care delivery.Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California. $28M / Post-IPO Equity / Oct 06, 2023
Magnis Energy Technologies Magnis Energy Technologies
Magnis Energy Technologies produces and conducts research on lithium-ion batteries. The production of lithium-ion batteries, which is essential for the use of electric mobility and energy storage, is carried out by a corporation with an ASX listing. They work together with C4V, a technical partner that has created anode and cathode batterymaterials that are protected by patents.Magnis also has a minority stake in C4V and has licensed their anode processing technology exclusively with the goal of producing high performance anode materials using ultra-high purity natural flake graphite from Magnis' Nachu Graphite Project in Tanzania. Magnis' Nachu project in Tanzania produces high-quality natural flake graphite concentrate, which is in high demand in the anode material market for lithium-ion batteries. Because of its distinct graphitic crystal structure and low impurities, it does not require expensive and environmentally hazardous chemicals for purification. $16.6M / Post-IPO Debt / Mar 24, 2023
Anteris Technologies Anteris Technologies
Admedus Ltd was established in June 2011, through the merger of Allied Medical Ltd an unlisted public company and bioMD Ltd an ASX listed company (ASX: BOD).The merger created a diversified healthcare group with assets in research & development, products in advanced clinical trials ready for commercialization and a successful sales, marketingand medical device distribution business. $24.3M / Post-IPO Equity / Feb 09, 2023
Hastings Technology Metals Hastings Technology Metals
Hastings Technology Metals aims to become Australia's largest producer of rare earth minerals by developing its Yangibana Rare Earths and Niobium Project. The Yangibana Project, located in Western Australia's Gascoyne region, includes one of the world's most valuable NdPr deposits, with a NdPr-to-Total Rare Earth Oxide ratio.Hastings is still evaluating downstream processing options, including the construction of a hydrometallurgical plant to capture a larger portion of the rare earth value chain. $30M / Post-IPO Equity / Mar 28, 2022
Gridiron BioNutrients Gridiron BioNutrients
Gridiron is in the CBD space with and has had a focused on the development and commercialization of high-quality innovative CBD products within the health and wellness marketplace. Gridiron strives to formulate and design products that maximize the human body's potential enabling individuals to heal faster, train longer and recover quicker. $4M / Post-IPO Equity / Nov 30, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Taiwan
Liberia
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Oman
Tajikistan
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
United Kingdom
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does L1 Capital invest in?

L1 Capital invests primarily in Mineral, Biotechnology and Mining startups, most often at Post-IPO Equity and Post-IPO Debt stage. Most of the 10 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact L1 Capital?

Public channels for L1 Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at L1 Capital?

The team at L1 Capital includes Andrew Lin (Senior Investment Analyst), Mark Landau (Co-founder, CIO & JMD) and Raphael Lamm (Co-founder, CIO & JMD). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
L1 Capital L1 Capital Find emails